Quantcast
Channel: PR Newswire:
Viewing all articles
Browse latest Browse all 52722

EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer

0
0
HUNTSVILLE, Ala., March 19, 2013 /PRNewswire/ -- EGEN, Inc. today announced that it has recently initiated a Phase I clinical trial of its novel immunotherapy agent, EGEN-001, in combination with PEGylated liposomal Doxorubicin or Lipodox for the treatment of recurrent ovarian...

Viewing all articles
Browse latest Browse all 52722

Latest Images

Trending Articles



click here for Latest and Popular articles on Electronic Design Automation (EDA)


Latest Images